On October 5th, the U.S. Food and Drug Administration (FDA) issued a request for comments regarding the abuse potential, actual abuse, medical usefulness, trafficking and impact of scheduling changes on the availability for medical use of 10 drug substances, including ketamine. ASPET has submitted comments articulating the Society’s objection to object to any adoption of an international regul…

  ASPET President Dr. Kenneth Thummel joined over 20 FASEB Society Presidents in signing a letter urging Congress to raise the spending caps and pass a bipartisan budget that includes increased funding for scientific research. Earlier this year, the importance of federal investment in biological and biomedical science and research was recognized by the House and Senate Appropriations Committees…

  The White House Office of Management and Budget (OMB) recently announced that it is seeking feedback on ways to reduce unnecessary reporting burden for recipients of federal grants and contracts. Information will be collected through the “National Dialogue website” and used to inform a two-year pilot study and other activities. The Federation of American Societies for Experimental Biology (FA…

  The Ad Hoc Group for Medical Research of the Association of American Medical Colleges (AAMC) has submitted a letter to the Senate Committee on Health, Educations, Labor and Pensions (HELP) to provide input and recommendations to enhance the role of NIH as they continue to work on their bipartisan innovation initiative. The letter makes the following recommendations: Stabilize the NIH budget thr…

  ASPET supports the biomedical research community in expressing disappointment in funding allocations recommended by House Appropriations Committee. ASPET had cosigned a letter to the Committee urging that the Fiscal Year (FY) 2016 302(b) allocation for the Labor, HHS, Education and Related Agencies Appropriations Subcommittee be restored to at least the FY 2010 level of $163.6 billion.